Confirma gets $17.5m for CAD:
This article was originally published in Clinica
Executive Summary
Confirma is looking to expand the applications of its CADstream computer-aided-detection technology with the $17.5m it raised in a series C financing. The Bellevue, Washington firm's system for breast MRI has a worldwide installed based of around a thousand units and the company is currently developing the technology for prostate MRI. The investment round was led by Telegraph Hill Partners and included the participation of new investor Fluke Venture Partners and Confirma's existing shareholders.
You may also be interested in...
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.